Enkephalinase: Selective peptide inhibitors |
| |
Authors: | Roger L. Hudgin Stella E. Charleson M. Zimmerman R. Mumford Paul L. Wood |
| |
Affiliation: | 1. Merck Frosst Laboratories, Dept. Pharmacology, Box 1005, Pointe Claire, Que. H9R 4P8, Canada;2. Merck Sharp and Dohme, Dept. Immunology, Rahway, N.J. 07065, USA. |
| |
Abstract: | A unique, CNS membrane bound enkephalinase is described with greatest activities being measured in the striatum of the mouse. This enzyme was resistant to inhibition by puromycin and bestatin which are potent aminopeptidase inhibitors and to the angiotensin converting enzyme inhibitors, captopril and the free acid of MK-421, which were also very weak inhibitors of aminopeptidase. However, the glycopeptide, phosphoramidon, and the hydroxamic acids, HO-NHCOCH(CH2CH(CH3)2)-CO-Ala-Gly-NH2 and HO-NHCOCH(CH2C6H5)-CO-Ala-Gly-NH2, were potent enkephalinase inhibitors with IC50's (nM) of 39, 3.1 and 8.4, respectively. These peptides remain to be tested . |
| |
Keywords: | Correspondence: Douglas Hospital Research Centre 6875 Boul. Lasalle Verdun Quebec H4H 1R3 |
本文献已被 ScienceDirect 等数据库收录! |
|